2021 Antimicrobial Resistance Benchmark report
30 November 2021
The third AMR Benchmark is an independent report that compares and analyses how pharmaceutical companies are responding to the crisis of antimicrobial resistance.
Despite progress by pharma against AMR, pace of change must accelerate.
More information: 2021 Antimicrobial Resistance Benchmark – accesstomedicinefoundation.org